iMANY, the leading provider of contract performance solutions, will address emerging issues and trends in government pricing and compliance for pharmaceutical manufacturers at the 15th Annual Medicaid Drug Rebate Program (MDRP) conference (http://www.iirusa.com/medicaiddrugrebates/home.xml) . Produced by the Institute for International Research, the MDRP conference will be held September 15-17, 2010 at the Marriott Downtown Magnificent Mile in Chicago. It is the premier conference for pharmaceutical manufacturers to gain critical insights into the ever changing, complex Medicaid Rebate regulations from industry thought leaders.
Jennifer Norton, Senior Director of Solutions Marketing at iMANY, will present on the topic of "Best Practices in Bundling and Discount Reallocation," an issue that received great attention following its introduction in the Deficit Reduction Act of 2005, but which holds particular relevance with the compliance requirements of the 2010 Patient Protection and Affordable Care Act (PPACA) as part of health care reform.
"Government pricing compliance will become an even greater priority for manufacturers in the coming years, as state and federal governments work to balance budgets and see the pharmaceutical industry as a key target," noted Ms. Norton. "Bundling practices have been a lightning rod issue in recent years and have only grown in complexity with the most recent regulatory changes for determining average manufacturer price (AMP). iMANY has been tracking the bundling and discount reallocation methodologies of dozens of companies and offers a unique perspective on this complex issue and its impact from recent legislative activities."
iMANY has been closely involved with the pharmaceutical industry's efforts to implement changes to their Medicaid, Medicare and 340B compliance processes. Participation in this conference further solidifies iMANY's commitment to helping the industry adjust and adapt to the compliance requirements of health care reform with the iMANY@ ContractSphere@ (http://www.imany.com/solutions/platform-architecture/contractsphere.html) platform, the industry's only fully integrated platform for contract lifecycle management.
According to P. Kevin Kilroy, President and Chief Executive Officer of iMANY, "Health care reform remains the single greatest issue affecting the pharmaceutical industry today. With a growing list of complexities to manage, manufacturers are relying more and more on a single, integrated solution to help them make a smooth transition. iMANY is committed to staying abreast of the issues and being the leading provider of health care reform compliance solutions."
At this year's MDRP conference, visitors to iMANY's exhibit booth will learn how the iMANY ContractSphere platform helps manufacturers comply with the recent changes to Medicaid, Medicare and 340B programs. The conference is expected to attract more than 400 attendees and will provide manufacturers with best practices in managing the increasing complexity in calculations and total program compliance.
About iMANY
iMANY is the leader in contract performance -- helping organizations improve the way they manage complex commercial and government contracting and compliance strategies by aligning actionable information with revenue-based transactions. The iMANY ContractSphere platform, the industry's only integrated solution for contract performance, optimizes the entire contract lifecycle, limits gross-to-net margin erosion and ensures compliance in today's heightened regulatory environment. Hundreds of organizations across 21 industries worldwide, including the top 10 life sciences companies, depend on iMANY to reveal insights that drive more profitable business relationships. For more information, please visit www.imany.com (http://www.imany.com) .
